Elevation Oncology Inc
Biotechnology
Healthcare
ELEV
23.30 M shares
NASDAQ US
traded
26 Jul 2023
listed
yes
open
1.35
52 week high
7.45
high
1.41
52 week low
1.32
low
1.34
growth
5.26 %
previous Close
1.35
P/E ratio
market cap
94.43 M
div yield
0
usd
Mar 2023
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top